Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs.
All Authors:
Authors
Vokinger KN, Kesselheim AS.
Author Profiles:
Persons
Aaron Seth Kesselheim
Publish Date:
Date
Journal:
Venue / Journal
Health Policy
, 
Additional Journal Information
123(8):721-727
Read Publication